Brian Taubenheim

Brian joined Belhaven Biopharma in 2022 as the Chief Operations Officer with the goal of transitioning the company from pre-clinical development to an organization capable of taking assets through the clinic and achieving marketing authorization. Prior to joining Belhaven, Brian founded and grew Wilco Consulting over the course of 9 years providing operational, technical, and data science services to startup and multinational companies in and adjacent to the pharmaceutical sector. He started his professional career in the CDMO industry and transitioned into pharmaceuticals holding roles in CMC development, operations management, business development, and therapeutic program lead. During that time, he has had the opportunity to work with partner companies and Agencies in the US, Europe, Canada, and Asia-Pacific. Brian has led and worked on programs with the US Biomedical Advanced Development Authority, National Institutes of Health, and Department of Defense from initial funding to supply of the Strategic National Stockpile. He holds a bachelor’s degree in chemistry from Lakeland University, master’s degree in business administration from Cardinal Stritch University, master’s certification in project management from the University of Wisconsin, and master’s degree in data science from Northwestern University.